Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum.
Gerdeman G, Lovinger DM. Gerdeman G, et al. J Neurophysiol. 2001 Jan;85(1):468-71. doi: 10.1152/jn.2001.85.1.468. J Neurophysiol. 2001. PMID: 11152748 Free article.
Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport.
Ronesi J, Gerdeman GL, Lovinger DM. Ronesi J, et al. Among authors: gerdeman gl. J Neurosci. 2004 Feb 18;24(7):1673-9. doi: 10.1523/JNEUROSCI.5214-03.2004. J Neurosci. 2004. PMID: 14973237 Free PMC article.
Context-specific reversal of cocaine sensitization by the CB1 cannabinoid receptor antagonist rimonabant.
Gerdeman GL, Schechter JB, French ED. Gerdeman GL, et al. Neuropsychopharmacology. 2008 Oct;33(11):2747-59. doi: 10.1038/sj.npp.1301648. Epub 2007 Dec 5. Neuropsychopharmacology. 2008. PMID: 18059436 Free article.
Emerging roles for endocannabinoids in long-term synaptic plasticity.
Gerdeman GL, Lovinger DM. Gerdeman GL, et al. Br J Pharmacol. 2003 Nov;140(5):781-9. doi: 10.1038/sj.bjp.0705466. Epub 2003 Sep 22. Br J Pharmacol. 2003. PMID: 14504143 Free PMC article. Review. No abstract available.
Postsynaptic endocannabinoid release is critical to long-term depression in the striatum.
Gerdeman GL, Ronesi J, Lovinger DM. Gerdeman GL, et al. Nat Neurosci. 2002 May;5(5):446-51. doi: 10.1038/nn832. Nat Neurosci. 2002. PMID: 11976704
It could be habit forming: drugs of abuse and striatal synaptic plasticity.
Gerdeman GL, Partridge JG, Lupica CR, Lovinger DM. Gerdeman GL, et al. Trends Neurosci. 2003 Apr;26(4):184-92. doi: 10.1016/S0166-2236(03)00065-1. Trends Neurosci. 2003. PMID: 12689769 Review.
Differential response to a selective cannabinoid receptor antagonist (SR141716: rimonabant) in female mice from lines selectively bred for high voluntary wheel-running behaviour.
Keeney BK, Raichlen DA, Meek TH, Wijeratne RS, Middleton KM, Gerdeman GL, Garland T Jr. Keeney BK, et al. Among authors: gerdeman gl. Behav Pharmacol. 2008 Dec;19(8):812-20. doi: 10.1097/FBP.0b013e32831c3b6b. Behav Pharmacol. 2008. PMID: 19020416
Wired to run: exercise-induced endocannabinoid signaling in humans and cursorial mammals with implications for the 'runner's high'.
Raichlen DA, Foster AD, Gerdeman GL, Seillier A, Giuffrida A. Raichlen DA, et al. Among authors: gerdeman gl. J Exp Biol. 2012 Apr 15;215(Pt 8):1331-6. doi: 10.1242/jeb.063677. J Exp Biol. 2012. PMID: 22442371 Free article. Clinical Trial.
Exercise-induced endocannabinoid signaling is modulated by intensity.
Raichlen DA, Foster AD, Seillier A, Giuffrida A, Gerdeman GL. Raichlen DA, et al. Among authors: gerdeman gl. Eur J Appl Physiol. 2013 Apr;113(4):869-75. doi: 10.1007/s00421-012-2495-5. Epub 2012 Sep 19. Eur J Appl Physiol. 2013. PMID: 22990628 Clinical Trial.